Bifidobacterium adolescentis

Last updated

Bifidobacterium adolescentis
Bifidobacterium adolescentis Gram.jpg
Bifidobacterium adolescentis Gram
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Kingdom: Bacillati
Phylum: Actinomycetota
Class: Actinomycetia
Order: Bifidobacteriales
Family: Bifidobacteriaceae
Genus: Bifidobacterium
Species:
B. adolescentis
Binomial name
Bifidobacterium adolescentis
Reuter 1963 (Approved Lists 1980)

Bifidobacterium adolescentis is an anaerobic species of bacteria found in the gastrointestinal tracts of humans and other primates. [1] It is one of the most abundant and prevalent Bifidobacterium species detected in human populations, especially in adults. [2] [3]

Research into health benefits

Bifidobacterium adolescentis has been studied for its health benefits, as strains have been shown to potentially protect against or improve recovery from several diseases, including liver-related, [4] metabolic, [5] allergic airway, [6] colitis, [7] arthritis, [8] and bacterial infections. [9] Strains have also been demonstrated to possess anti-inflammatory, [10] anxiolytic, [11] antioxidant, [12] antidepressant, [13] and/or antiviral [14] activity.

In addition, B. adolescentis strains have been of interest for their ability to metabolize various compounds. This includes prebiotics such as arabinoxylan, [15] XOS, [16] and GOS. [17] Some strains of B. adolescentis are also adept at metabolizing lactose, and may reduce symptoms associated with lactose intolerance. [18] Like other bifidobacteria, B. adolescentis typically produce acetic acid and lactic acid, though the exact ratio depends on the bacterial strain, the carbohydrate being metabolized, and the growth conditions. [19] Production of short chain fatty acids and lactic acid in the colon is associated with health benefits. [20]

Bifidobacterium adolescentis contributes to the production of GABA, [21] a neurotransmitter that plays a role in reducing stress and anxiety. Some B. adolescentis strains can also synthesize B vitamins, [22] such as folic acid. [23] One strain has been shown to be bifidogenic in the GI tract. That is, the presence of one B. adolescentis strain enhances the growth of all bifidobacteria, a group that generally confers positive health benefits [24] and is important for healthy aging. [25]

Some B. adolescentis have been shown to strengthen the intestinal barrier [26] that is important in preventing pathogenic bacteria and toxins from traveling from the gut lumen into the body. Another study suggested the opposite effect: an undefined B. adolescentis strain was observed to disrupt gut barrier functions in colonic epithelial cell cultures. [27]

Multiple probiotics are marked as containing B. adolescentis, however there are a limited number of commercially available strains (PRL2019, [21] iVS1 [18] [26] ) with published scientific studies supporting their health claims.

References

  1. Lugli, Gabriele Andrea; Alessandri, Giulia; Milani, Christian; Mancabelli, Leonardo; Ruiz, Lorena; Fontana, Federico; Borragán, Santiago; González, Andrea; Turroni, Francesca; Ossiprandi, Maria Cristina; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco (August 2020). "Evolutionary development and co-phylogeny of primate-associated bifidobacteria". Environmental Microbiology. 22 (8): 3375–3393. doi:10.1111/1462-2920.15108. hdl: 10261/223012 . PMID   32515117. S2CID   219552451.
  2. Derrien, Muriel; Turroni, Francesca; Ventura, Marco; van Sinderen, Douwe (October 2022). "Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood". Trends in Microbiology. 30 (10): 940–947. doi: 10.1016/j.tim.2022.04.004 . PMID   35577716. S2CID   248783095.
  3. Pasolli, Edoardo; Schiffer, Lucas; Manghi, Paolo; Renson, Audrey; Obenchain, Valerie; Truong, Duy Tin; Beghini, Francesco; Malik, Faizan; Ramos, Marcel; Dowd, Jennifer B; Huttenhower, Curtis; Morgan, Martin; Segata, Nicola; Waldron, Levi (November 2017). "Accessible, curated metagenomic data through ExperimentHub". Nature Methods. 14 (11): 1023–1024. doi:10.1038/nmeth.4468. PMC   5862039 . PMID   29088129.
  4. Long, Xiaoxue; Liu, Dan; Gao, Qiongmei; Ni, Jiacheng; Qian, Lingling; Ni, Yueqiong; Fang, Qichen; Jia, Weiping; Li, Huating (30 December 2021). "Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity". Frontiers in Endocrinology. 12: 773340. doi: 10.3389/fendo.2021.773340 . PMC   8756294 . PMID   35035378.
  5. Chen, Jinjin; Wang, Ren; Li, Xiao-Fang; Wang, Rui-Liang (28 May 2012). "Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome". British Journal of Nutrition. 107 (10): 1429–1434. doi: 10.1017/S0007114511004491 . PMID   21914236. S2CID   3480942.
  6. Casaro, M. C., Crisma, A. R., Vieira, A. T., Silva, G. H. M., Mendes, E., Ribeiro, W. R., Martins, F. S., Ferreira, C. M. (10 April 2018). "Prophylactic Bifidobacterium adolescentis ATTCC 15703 supplementation reduces partially allergic airway disease in Balb/c but not in C57BL/6 mice". Beneficial Microbes. 9 (3). Wageningen Academic Publishers: 465–476. doi:10.3920/BM2017.0073. ISSN   1876-2891. PMID   29633635.
  7. Wu, W., Wang, Y., Zou, J., Long, F., Yan, H., Zeng, L., Chen, Y. (5 January 2017). "Bifidobacterium adolescentis protects against necrotizing enterocolitis and upregulates TOLLIP and SIGIRR in premature neonatal rats". BMC Pediatrics. 17 (1). BioMed Central Ltd.: 1–7. doi: 10.1186/s12887-016-0759-7 . ISSN   1471-2431. PMC   5217633 . PMID   28056921.
  8. Fan, Z., Yang, B., Ross, R. P., Stanton, C., Shi, G., Zhao, J., Zhang, H., Chen, W. (26 May 2020). "Protective effects of Bifidobacterium adolescentis on collagen-induced arthritis in rats depend on timing of administration". Food & Function. 11 (5). The Royal Society of Chemistry: 4499–4511. doi:10.1039/D0FO00077A. ISSN   2042-650X. PMID   32383727. S2CID   218555170.
  9. Wittmann, A., Autenrieth, I. B., Frick, J. S. (20 August 2013). "Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection". PLOS ONE. 8 (8). Public Library of Science: e71338. Bibcode:2013PLoSO...871338W. doi: 10.1371/JOURNAL.PONE.0071338 . ISSN   1932-6203. PMC   3748105 . PMID   23977019.
  10. Kawabata, K., Baba, N., Sakano, T., Hamano, Y., Taira, S., Tamura, A., Baba, S., Natsume, M., Ishii, T., Murakami, S., Ohigashi, H. (3 April 2018). "Functional properties of anti-inflammatory substances from quercetin-treated Bifidobacterium adolescentis". Bioscience, Biotechnology, and Biochemistry. 82 (4). Oxford Academic: 689–697. doi: 10.1080/09168451.2017.1401916 . ISSN   0916-8451. PMID   29165050. S2CID   2092475.
  11. Jang, H. M., Jang, S. E., Han, M. J., Kim, D. H. (3 October 2017). "Anxiolytic-like effect of Bifidobacterium adolescentis IM38 in mice with or without immobilisation stress". Beneficial Microbes. 9 (1). Wageningen Academic Publishers: 123–132. doi:10.3920/BM2016.0226. ISSN   1876-2891. PMID   28969445.
  12. Huang, H. C., Chang, T. M. (14 September 2012). "Antioxidative properties and inhibitory effect of Bifidobacterium adolescentis on melanogenesis". World Journal of Microbiology and Biotechnology. 28 (9). Springer: 2903–2912. doi:10.1007/s11274-012-1096-0. ISSN   0959-3993. PMID   22806726. S2CID   21042891.
  13. Guo, Y., Xie, J. P., Deng, K., Li, X., Yuan, Y., Xuan, Q., Xie, J., He, X. M., Wang, Q., Li, J. J., Luo, H. R. (22 May 2019). "Prophylactic effects of Bifidobacterium adolescentis on anxiety and depression-like phenotypes after chronic stress: a role of the gut microbiota-inflammation axis". Frontiers in Behavioral Neuroscience. 13. Frontiers Media SA: 126. doi: 10.3389/FNBEH.2019.00126 . ISSN   1662-5153. PMC   6591489 . PMID   31275120.
  14. Lee, D. K., Kang, J. Y., Shin, H. S., Park, I. H., Ha, N. J. (9 December 2013). "Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus". Archives of Pharmacal Research. 36 (12). Springer: 1525–1532. doi:10.1007/s12272-013-0141-3. ISSN   0253-6269. PMID   23657805. S2CID   255555304.
  15. Van Laere, K. M. J., Beldman, G., Voragen, A. G. J. (1997). "A new arabinofuranohydrolase from Bifidobacterium adolescentis able to remove arabinosyl residues from double-substituted xylose units in arabinoxylan". Appl Microbiol Biotechnol. 47 (3): 231–235. doi:10.1007/s002530050918. PMID   9114514. S2CID   2347318.
  16. Yang, J., Tang, Q., Xu, L., Li, Z., Ma, Y., Yao, D. (1 November 2019). "Combining of transcriptome and metabolome analyses for understanding the utilization and metabolic pathways of Xylo-oligosaccharide in Bifidobacterium adolescentis ATCC 15703". Food Science & Nutrition. 7 (11). Wiley-Blackwell: 3480–3493. doi:10.1002/FSN3.1194. ISSN   2048-7177. PMC   6848847 . PMID   31762999.
  17. Krumbeck, J. A., Maldonado-Gomez, M. X., Martínez, I., Frese, S. A., Burkey, T. E., Rasineni, K., Ramer-Tait, A. E., Harris, E. N., Hutkins, R. W., Walter, J. (2015). "In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications". Applied and Environmental Microbiology. 81 (7). Appl Environ Microbiol: 2455–2465. Bibcode:2015ApEnM..81.2455K. doi:10.1128/AEM.03903-14. ISSN   1098-5336. PMC   4357922 . PMID   25616794.
  18. 1 2 Ramakrishnan, Monica; Cross, Tzu-Wen L.; Organski, Anna Clapp; Saiprasad, Sindusha Mysore; Simpson, Abigayle M. R.; Tancredi, Daniel J.; Van Haute, Mallory J.; Christensen, Chloe M.; Lewis, Zachery T.; Auchtung, Thomas A.; Walter, Jens; Hutkins, Robert; Savaiano, Dennis A. (2025). "Two-week supplementation of Bifidobacterium adolescentis iVS-1 reduces symptoms associated with lactose intolerance in lactose maldigesters". Gut Microbes Reports. 2 (1). doi: 10.1080/29933935.2025.2508199 .
  19. McLaughlin, H. P., Motherway, M. O. C., Lakshminarayanan, B., Stanton, C., Paul Ross, R., Brulc, J., Menon, R., O'Toole, P. W., Sinderen, D. van (6 June 2015). "Carbohydrate catabolic diversity of bifidobacteria and lactobacilli of human origin". International Journal of Food Microbiology. 203. Elsevier B.V.: 109–121. doi:10.1016/j.ijfoodmicro.2015.03.008. ISSN   1879-3460. PMID   25817019.
  20. Xiong, R. G., Zhou, D. D., Wu, S. X., Huang, S. Y., Saimaiti, A., Yang, Z. J., Shang, A., Zhao, C. N., Gan, R. Y., Li, H. Bin (2022), "Health Benefits and Side Effects of Short-Chain Fatty Acids", Foods, 11 (18), MDPI: 2863, doi: 10.3390/foods11182863 , PMC   9498509 , PMID   36140990
  21. 1 2 Duranti, S., Ruiz, L., Lugli, G. A., Tames, H., Milani, C., Mancabelli, L., Mancino, W., Longhi, G., Carnevali, L., Sgoifo, A., Margolles, A., Ventura, M., Ruas-Madiedo, P., Turroni, F. (1 December 2020). "Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA". Scientific Reports. 10 (1). Nature Research: 14112. Bibcode:2020NatSR..1014112D. doi:10.1038/s41598-020-70986-z. ISSN   2045-2322. PMC   7445748 . PMID   32839473.
  22. Arunachalam, K. D., Author, C., Arunachalam, K. D., Arunachalam, K. (1999), "Role of Bifidobacteria in Nutrition, Medicine, and Technology", Nutrition Research, 19 (10): 1559–1597, doi:10.1016/S0271-5317(99)00112-8
  23. Rossi, M., Amaretti, A., Raimondi, S. (2011), "Folate production by probiotic bacteria", Nutrients, 3 (1), MDPI AG: 118–134, doi: 10.3390/nu3010118 , PMC   3257725 , PMID   22254078
  24. Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B., Margolles, A. (19 May 2017). "Bifidobacteria and Their Health-Promoting Effects". Microbiology Spectrum. 5 (3). American Society for Microbiology. doi:10.1128/microbiolspec.bad-0010-2016. ISSN   2165-0497. PMC   11687494 . PMID   28643627.
  25. Kumar, M., Babaei, P., Ji, B., Nielsen, J. (28 October 2016). "Human gut microbiota and healthy aging: Recent developments and future prospective". Nutrition and Healthy Aging. 4 (1). IOS Press: 3–16. doi:10.3233/nha-150002. ISSN   2451-9480. PMC   5166512 . PMID   28035338.
  26. 1 2 Krumbeck, J. A., Rasmussen, H. E., Hutkins, R. W., Clarke, J., Shawron, K., Keshavarzian, A., Walter, J. (28 June 2018). "Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics". Microbiome. 6 (1). BioMed Central Ltd.: 121. doi: 10.1186/s40168-018-0494-4 . ISSN   2049-2618. PMC   6022452 . PMID   29954454.
  27. Bootz-Maoz, H., Pearl, A., Melzer, E., Malnick, S., Sharon, E., Bennet, Y., Tsentsarevsky, R., Abuchatzera, S., Amidror, S., Aretz, E., Azriel, S., Gam Ze Letova, C., Naama, M., Shoval, I., Yaron, O., Karako-Lampert, S., Bel, S., Yissachar, N. (15 November 2022). "Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome". Cell Reports. 41 (7). Elsevier B.V.: 111657. doi: 10.1016/j.celrep.2022.111657 . ISSN   2211-1247. PMID   36384106.